about
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics f...
Read More
0.42
0.00
(0.00%)
690.2K
XNAS Volume
XNAS 10 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
GT Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..